Mouse Anti-ACAN Recombinant Antibody (V2-179203) (CBMAB-A0461-YC)

König, K. C., Lahm, H., Dreßen, M., Doppler, S. A., Eichhorn, S., Beck, N., ... & Krane, M. (2021). Aggrecan: a new biomarker for acute type A aortic dissection. Scientific Reports, 11(1), 1-12.

Schmidt, S., Stapf, C., Schmutzler, S., Lachmann, I., Arendt, T., Holzer, M., ... & Morawski, M. (2020). Aggrecan modulates the expression and phosphorylation of tau in a novel bigenic TauP301L‐Acan mouse model. European Journal of Neuroscience.

Tashkandi, M. M., Alsaqer, S. F., Alhousami, T., Ali, F., Wu, Y. C., Shin, J., ... & Bais, M. V. (2020). LOXL2 promotes aggrecan and gender-specific anabolic differences to TMJ cartilage. Scientific reports, 10(1), 1-13.

de Andrade, D. G. A., Basso, R. M., Magro, A. J., Laufer-Amorim, R., Borges, A. S., & de Oliveira-Filho, J. P. (2020). Evaluation of a new variant in the aggrecan gene potentially associated with chondrodysplastic dwarfism in Miniature horses. Scientific reports, 10(1), 1-10.

Dupuis, L. E., Nelson, E. L., Hozik, B., Porto, S. C., Rogers-DeCotes, A., Fosang, A., & Kern, C. B. (2019). Adamts5−/− mice exhibit altered aggrecan proteolytic profiles that correlate with ascending aortic anomalies. Arteriosclerosis, thrombosis, and vascular biology, 39(10), 2067-2081.

Struck, A. K., Dierks, C., Braun, M., Hellige, M., Wagner, A., Oelmaier, B., ... & Distl, O. (2018). A recessive lethal chondrodysplasia in a miniature zebu family results from an insertion affecting the chondroitin sulfat domain of aggrecan. BMC genetics, 19(1), 1-9.

Zhang, B., Guo, W., Sun, C., Duan, H. Q., Yu, B. B., Mu, K., ... & Feng, S. Q. (2018). Dysregulated MiR-3150a-3p promotes lumbar intervertebral disc degeneration by targeting aggrecan. Cellular Physiology and Biochemistry, 45(6), 2506-2515.

Sentchordi‐Montané, L., Aza‐Carmona, M., Benito‐Sanz, S., Barreda‐Bonis, A. C., Sánchez‐Garre, C., Prieto‐Matos, P., ... & Heath, K. E. (2018). Heterozygous aggrecan variants are associated with short stature and brachydactyly: description of 16 probands and a review of the literature. Clinical endocrinology, 88(6), 820-829.

Rowlands, D., Lensjø, K. K., Dinh, T., Yang, S., Andrews, M. R., Hafting, T., ... & Dick, G. (2018). Aggrecan directs extracellular matrix-mediated neuronal plasticity. Journal of Neuroscience, 38(47), 10102-10113.

Gkourogianni, A., Andrew, M., Tyzinski, L., Crocker, M., Douglas, J., Dunbar, N., ... & Dauber, A. (2017). Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations. The Journal of Clinical Endocrinology & Metabolism, 102(2), 460-469.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols